vs
Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and INTRUSION INC (INTZ). Click either name above to swap in a different company.
bioAffinity Technologies, Inc. is the larger business by last-quarter revenue ($1.6M vs $1.5M, roughly 1.1× INTRUSION INC). INTRUSION INC runs the higher net margin — -190.7% vs -197.0%, a 6.2% gap on every dollar of revenue. On growth, INTRUSION INC posted the faster year-over-year revenue change (-11.6% vs -27.8%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-2.6M). Over the past eight quarters, INTRUSION INC's revenue compounded faster (14.4% CAGR vs -18.6%).
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
BIAF vs INTZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6M | $1.5M |
| Net Profit | $-3.1M | $-2.8M |
| Gross Margin | — | 74.3% |
| Operating Margin | -196.9% | -192.4% |
| Net Margin | -197.0% | -190.7% |
| Revenue YoY | -27.8% | -11.6% |
| Net Profit YoY | -5.7% | -44.4% |
| EPS (diluted) | $-3.59 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6M | $1.5M | ||
| Q3 25 | $1.4M | $2.0M | ||
| Q2 25 | $1.3M | $1.9M | ||
| Q1 25 | $1.9M | $1.8M | ||
| Q4 24 | $2.2M | $1.7M | ||
| Q3 24 | $2.4M | $1.5M | ||
| Q2 24 | $2.4M | $1.5M | ||
| Q1 24 | $2.4M | $1.1M |
| Q4 25 | $-3.1M | $-2.8M | ||
| Q3 25 | $-5.1M | $-2.1M | ||
| Q2 25 | $-4.1M | $-2.0M | ||
| Q1 25 | $-2.7M | $-2.1M | ||
| Q4 24 | $-3.0M | $-2.0M | ||
| Q3 24 | $-2.0M | $-2.0M | ||
| Q2 24 | $-2.1M | $-2.1M | ||
| Q1 24 | $-2.0M | $-1.7M |
| Q4 25 | — | 74.3% | ||
| Q3 25 | — | 76.6% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 75.7% | ||
| Q4 24 | — | 74.9% | ||
| Q3 24 | — | 77.1% | ||
| Q2 24 | — | 76.0% | ||
| Q1 24 | — | 80.0% |
| Q4 25 | -196.9% | -192.4% | ||
| Q3 25 | -158.6% | -108.6% | ||
| Q2 25 | -198.2% | -111.4% | ||
| Q1 25 | -141.7% | -117.9% | ||
| Q4 24 | -133.5% | -113.5% | ||
| Q3 24 | -84.0% | -135.5% | ||
| Q2 24 | -87.1% | -139.2% | ||
| Q1 24 | -80.8% | -218.6% |
| Q4 25 | -197.0% | -190.7% | ||
| Q3 25 | -349.3% | -106.5% | ||
| Q2 25 | -319.9% | -109.0% | ||
| Q1 25 | -143.5% | -118.2% | ||
| Q4 24 | -134.4% | -116.8% | ||
| Q3 24 | -85.1% | -136.3% | ||
| Q2 24 | -88.0% | -141.6% | ||
| Q1 24 | -81.5% | -151.7% |
| Q4 25 | $-3.59 | $-0.15 | ||
| Q3 25 | $-4.74 | $-0.10 | ||
| Q2 25 | $-0.17 | $-0.10 | ||
| Q1 25 | $-0.16 | $-0.11 | ||
| Q4 24 | $-17.27 | $0.19 | ||
| Q3 24 | $-4.84 | $-0.35 | ||
| Q2 24 | $-0.19 | $-0.53 | ||
| Q1 24 | $-0.20 | $-0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $7.3M |
| Total Assets | $11.0M | $10.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $3.6M | ||
| Q3 25 | $7.7M | $4.5M | ||
| Q2 25 | $802.8K | $8.4M | ||
| Q1 25 | $444.7K | $10.7M | ||
| Q4 24 | $1.1M | $4.9M | ||
| Q3 24 | $756.6K | $1.1M | ||
| Q2 24 | $801.3K | $1.5M | ||
| Q1 24 | $2.5M | $122.0K |
| Q4 25 | $7.3M | $7.3M | ||
| Q3 25 | $8.9M | $9.8M | ||
| Q2 25 | $-2.1M | $11.6M | ||
| Q1 25 | $1.4M | $13.4M | ||
| Q4 24 | $2.6M | $6.3M | ||
| Q3 24 | $3.1M | $2.6M | ||
| Q2 24 | $3.4M | $2.9M | ||
| Q1 24 | $5.3M | $-1.2M |
| Q4 25 | $11.0M | $10.4M | ||
| Q3 25 | $11.5M | $13.7M | ||
| Q2 25 | $4.8M | $16.4M | ||
| Q1 25 | $5.5M | $18.0M | ||
| Q4 24 | $6.5M | $11.5M | ||
| Q3 24 | $6.6M | $7.4M | ||
| Q2 24 | $6.7M | $7.5M | ||
| Q1 24 | $8.0M | $5.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.6M | $-531.0K |
| Free Cash FlowOCF − Capex | $-2.6M | $-549.0K |
| FCF MarginFCF / Revenue | -160.7% | -37.1% |
| Capex IntensityCapex / Revenue | 0.0% | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.6M | $-531.0K | ||
| Q3 25 | $-2.5M | $-3.0M | ||
| Q2 25 | $-2.6M | $-1.6M | ||
| Q1 25 | $-1.6M | $-1.7M | ||
| Q4 24 | $-1.7M | $-178.0K | ||
| Q3 24 | $-1.7M | $-2.1M | ||
| Q2 24 | $-1.5M | $-2.9M | ||
| Q1 24 | $-2.3M | $-1.1M |
| Q4 25 | $-2.6M | $-549.0K | ||
| Q3 25 | $-2.5M | $-3.0M | ||
| Q2 25 | $-2.7M | $-1.9M | ||
| Q1 25 | $-1.7M | $-2.1M | ||
| Q4 24 | $-1.7M | $-645.0K | ||
| Q3 24 | $-1.7M | $-2.1M | ||
| Q2 24 | $-1.6M | $-3.0M | ||
| Q1 24 | $-2.4M | $-1.2M |
| Q4 25 | -160.7% | -37.1% | ||
| Q3 25 | -171.8% | -153.2% | ||
| Q2 25 | -209.6% | -101.1% | ||
| Q1 25 | -91.3% | -117.3% | ||
| Q4 24 | -76.0% | -38.5% | ||
| Q3 24 | -73.1% | -140.4% | ||
| Q2 24 | -65.1% | -202.3% | ||
| Q1 24 | -99.2% | -104.2% |
| Q4 25 | 0.0% | 1.2% | ||
| Q3 25 | 0.3% | 1.7% | ||
| Q2 25 | 1.1% | 17.8% | ||
| Q1 25 | 2.7% | 22.1% | ||
| Q4 24 | 0.0% | 27.9% | ||
| Q3 24 | 0.4% | 2.2% | ||
| Q2 24 | 1.2% | 2.1% | ||
| Q1 24 | 1.7% | 5.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
